
ACCREDITATION & DISCLOSURES
Activity Overview
The Ophthalmology 360® Virtual Summit Series will cover diverse conditions affecting the anterior segment and retina. Each session will be approximately 1 hour, consisting of a 45- to 50-minute prerecorded roundtable discussion followed by a 10-minute live Q&A with the faculty during the event.
Following the virtual conference, sessions will become enduring for 1 year, during which time they will be eligible for CE/CME and COPE credit. Participants will only be eligible to receive credit for the sessions that they have not already claimed credit for as part of the live event.
Learning Objectives
After attending the 2023 Ophthalmology 360® Virtual Summit Series, participants should be able to:
- Describe the best approaches to diagnosis, treatment selection, and ongoing management of varied ophthalmologic issues
- Discuss the latest clinical research in ophthalmology, including the impact of recent trials and emerging therapies on patient care
- Explain advances and new techniques in ophthalmic surgery and medical treatment of eye diseases
- Implement the latest methods and data into clinical practice for the improved care of patients with ocular disorders and diseases
Target Audience
This activity is designed for an audience of Physicians and Ophthalmologists.
Criteria for Success
There is no fee to participate in this activity. Statements of credit will be awarded based on the participant's attendance. A statement of credit will be available upon completion of an online evaluation/claim credit form available at:
Please claim your credit by August 14, 2023
If you have any questions about this CE activity, please contact AKH Inc at Ketrea@akhcme.com
If you have any questions about this CE activity, please contact AKH Inc at Ketrea@akhcme.com


ADA Statement
International Healthcare Education and AKH, Inc. comply with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity requires accommodation, please call 908-505-8899, ext. 202.
Innovation Theaters
Innovation Theaters are nonaccredited, informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease-states or products. No CE/CME credits are offered for participating in these programs.
Statement on Brand Names
Some sessions that are part of this continuing medical education activity include brand names. This is for participant clarity purposes only. No product promotion or recommendation should be inferred.
Copyright
Copyright © 2023 by International Healthcare Media, LLC. All rights reserved.
Disclosures
Name |
Relationship | Commercial Interest |
Pinakin Davey OD, PhD, FARVO (faculty) | Consultant, Stock, Speaker | EyePromise LLC St Louis Missouri |
Consultant | Guardion Health Sciences | |
Stock | Globe Biomedical | |
Speaker | Sanofi Genzyme | |
Speaker | Innova USA | |
Kendall Donaldson MD (faculty) | Consultant | Alcon |
Consultant | Allergan | |
Consultant | Johnson & Johnson | |
Consultant | Dompe | |
Consultant | Novartis | |
Consultant | Tarsus | |
Consultant | Bausch + Lomb | |
Consultant | Zeiss | |
Consultant | LensAR | |
Consultant | Acufocus | |
Consultant | Lumenis | |
Consultant | Kala | |
Consultant | Oyster Point | |
Eric Donnenfeld MD (faculty) | Consultant, Ownership | Aeon |
Consultant | Allegro | |
Consultant | Allergan | |
Consultant | Alcon | |
Consultant, Ownership | Aurion | |
Consultant | Avellino Labs | |
Ownership | Avedro | |
Consultant | Bausch + Lomb | |
Consultant, Ownership | CorneaGen | |
Consultant, Ownership | Covalent | |
Consultant | CRST | |
Consultant, Ownership | Crystilex | |
Consultant | BVI | |
Consultant | Blephex | |
Consultant | Dompe | |
Consultant, Ownership | ELT Sight | |
Consultant, Ownership | EyePoint Pharma | |
Consultant | Foresight | |
Consultant, Ownership | Glaukos | |
Consultant, Ownership | Ivantis | |
Consultant | Johnson & Johnson | |
Consultant | Kala | |
Consultant | Katena | |
Consultant, Ownership | Lacripen | |
Consultant, Ownership | LayerBio | |
Consultant, Ownership | LensGen | |
Consultant, Ownership | Mati Pharmaceuticals | |
Consultant, Ownership | Melt Pharmaceuticals | |
Consultant, Ownership | MDBackline | |
Consultant | Merck | |
Consultant, Ownership | Mimetogen | |
Consultant, Ownership | MOA | |
Consultant | Nanowafer | |
Consultant, Ownership | Novabay | |
Consultant | Novartis | |
Consultant | Novaliq | |
Ownership | Ocuhub | |
Consultant, Ownership | Ocular Innovations | |
Consultant, Ownership | Oculis | |
Consultant | Odyssey | |
Consultant | Omega Ophthalmics | |
Consultant | Oyster PointTherapeutics | |
Consultant | Pfizer | |
Consultant, Ownership | Pogotec | |
Consultant | Ocuhub | |
Consultant | Omeros | |
Ownership | Orasis | |
Consultant | PRN | |
Consultant, Ownership | Rayner | |
Consultant, Ownership | ReTear | |
Consultant, Ownership | RPS | |
Consultant | Shire | |
Consultant, Ownership | Strathspey Crown | |
Consultant | SUN | |
Consultant, Ownership | Surface | |
Consultant, Ownership | Tarsus | |
Consultant, Ownership | Tearlab | |
Consultant | Tearscience | |
Consultant | Thea | |
Consultant, Ownership | Veracity | |
Consultant, Ownership | Versant Ventures | |
Consultant, Ownership | Visionary Ventures | |
Consultant, Ownership | Visus | |
Consultant | Zeiss | |
James Dunn, MD (faculty) | N/A | Nothing to disclose |
Lisa Faia MD (faculty) | Advisor, Speaker | Genentech/Roche |
Speaker | AbbVie/Allergan | |
Speaker | EyePoint | |
Speaker | Iveric Bio | |
Marjan Farid MD (faculty) | Advisor, Consultant | Alcon |
Advisor, Consultant | Alderya Therapeutics | |
Advisor, Consultant | Allergan | |
Advisor, Consultant | Bausch + Lomb | |
Advisor, Consultant | Bio-Tissue | |
Advisor, Consultant | Carl Zeiss Meditec | |
Advisor, Consultant | CorneaGen | |
Advisor, Consultant | Johnson & Johnson Vision | |
Advisor, Consultant | Novartis, Alcon Pharmaceuticals | |
Advisor, Consultant | Orasis Pharmaceuticals Inc | |
Advisor, Consultant | Oyster Point Pharma | |
Advisor, Consultant | Sun Ophthalmics | |
Advisor, Consultant | Tarsus | |
Advisor, Consultant | Kala Pharmaceuticals | |
Avni Finn MD, MBA (faculty) | Advisor | Genentech |
Preeya Gupta MD (faculty) | Consultant | Azura |
Consultant | Alcon | |
Consultant | Aldeyra | |
Consultant | Allergan | |
Consultant | Expert Opinion | |
Consultant | HanAll Biopharma | |
Consultant | J&J Vision | |
Consultant | Kala | |
Consultant | New World Medical | |
Consultant | Novartis | |
Consultant | Ocular Science | |
Consultant | Ocular Therapeutix | |
Consultant | Orasis | |
Consultant | Oyster Point | |
Consultant | Sight Sciences | |
Consultant | Spyglass | |
Consultant | Surface Ophthalmics | |
Consultant | Sun Pharmaceuticals | |
Consultant | Tear Lab | |
Consultant | Tear Clear | |
Consultant | Tissue Tech, Inc | |
Consultant | Visionology | |
Consultant | Zeiss | |
Elise Kramer OD, FAAO, FSLS, FBCLA (faculty) | Advisor, Consultant | Allergan |
Advisor, Consultant, Speaker | Avellino | |
Advisor, Consultant, Speaker | Contamac | |
Advisor, Consultant, Speaker | Dompe | |
Advisor, Consultant | Euclid | |
Advisor, Consultant | Ocuphire | |
Advisor, Consultant | Orasis | |
Advisor, Consultant | Oyster Pointe Pharmaceuticals | |
Advisor, Consultant, Speaker | RegenerEyes | |
Advisor, Consultant, Speaker | RVL | |
Advisor, Consultant | Tarsus | |
Advisor, Consultant, Speaker | Visionary Optics | |
Shan Lin MD (faculty) | Consultant | IRIDEX Corporation |
Stock | Claris | |
Speaker | Bausch + Lomb | |
Jennifer Loh MD (faculty) | Advisor, Consultant, Speaker | Alcon |
Advisor, Consultant, Speaker | Allergan | |
Advisor, Consultant | Bausch + Lomb | |
Advisor, Consultant | Johnson & Johnson | |
Advisor, Consultant | LensAr | |
Advisor, Consultant | Novartis | |
Advisor, Consultant | Novabay | |
Advisor, Consultant | Ocular Science | |
Advisor, Consultant | Orasis | |
Advisor, Consultant, Research, Speaker | Sight Sciences | |
Advisor, Consultant, Speaker | Sun Ophthalmics | |
Advisor, Consultant | Tarsus | |
Advisor, Consultant | Visus | |
Advisor, Consultant | Zeiss | |
Andrew Moshfeghi MD, MBA (faculty) | Consultant, Research | Regeneron |
Consultant, Research | Genentech/Roche | |
Consultant, Research | Novartis | |
Consultant | Allergan | |
Consultant | Alimera | |
Consultant, Stock | Ocular Therapeutix | |
Consultant, Stock | Valitor | |
Consultant | OcuTerra | |
Consultant | Ainsly ltd; dba Waldo | |
Consultant, Stock | Pr3vent | |
Cathleen McCabe MD (faculty) | Advisor, Consultant | Abbvie |
Advisor, Consultant, Speaker | Alcon | |
Advisor, Consultant, Speaker | Allergan | |
Advisor, Consultant, Speaker | Bausch + Lomb | |
Advisor, Consultant, Speaker | Carl Zeiss | |
Advisor, Consultant | Dompe | |
Consultant | Easee | |
Advisor, Consultant, Stock | Engage Technologies | |
Advisor, Consultant, Speaker | EyePoint | |
Speaker | Glaukos | |
Advisor, Consultant | ImprimisRX | |
Advisor, Consultant | ISTAR Medical | |
Advisor, Consultant, Speaker | Ivantis | |
Speaker | Lensar | |
Advisor, Consultant, Speaker | Novartis | |
Advisor, Consultant, Speaker | Ocular Therapeutix | |
Advisor, Consultant | Ocuphire | |
Advisor, Consultant, Speaker | Omeros | |
Advisor, Consultant | Orasis | |
Advisor, Consultant | Quidel EyeHealth | |
Speaker | RX Sight | |
Advisor, Consultant | Science Based Health | |
Advisor, Consultant, Speaker | Sight Sciences | |
Advisor, Consultant | Sun Ophthalmics | |
Advisor | SpyGlass | |
Speaker | Tarsus Pharmaceuticals | |
Advisor, Consultant | Visus Therapeutics | |
Leslie O'Dell OD FAAO 5 (faculty) | N/A | Nothing to disclose |
Constance Okeke MD, MSCE (faculty) | Consultant, Speaker | Allergan |
Speaker | Bausch + Lomb | |
Consultant | Corza Medical | |
Consultant, Speaker | Alcon | |
Consultant, Speaker | New World Medical | |
Consultant | Glaukos | |
Consultant | MST | |
Consultant | Santen | |
Consultant, Researcher, Speaker | Sight Sciences | |
Nathan Radcliffe MD (faculty) | Consultant | Alderya |
Consultant | Avellino | |
Consultant | Aerie | |
Consultant | Alcon Vision | |
Consultant | Alimera Sciences | |
Consultant | Allergan/AbbVie | |
Consultant | Bausch + Lomb | |
Consultant | Beaver-Visitec International | |
Consultant | Belkin | |
Consultant | CATS | |
Consultant | Carl Zeiss Meditec | |
Consultant | Dompe | |
Consultant | Ellex | |
Consultant | ELIOS Vision | |
Consultant | Equinox | |
Consultant | Eyepoint | |
Consultant | Glaukos | |
Consultant | Iridex | |
Consultant | IrisVision | |
Consultant | Kala | |
Consultant | Lumenis | |
Consultant | New World Medical | |
Consultant | Novartis | |
Consultant | Ocular Science | |
Consultant | Ocular Therapeutix | |
Consultant | Omeros | |
Consultant | Reichert | |
Consultant | Santen | |
Consultant | Shire | |
Consultant | Sight Sciences | |
Consultant | Spyglass | |
Consultant | Tarsus | |
Consultant | Thea | |
Consultant | TearClear | |
Consultant | ViaLase | |
Mohammad Rafieetary OD (faculty) | Consultant | Heidelberg |
Consultant, Speaker | Apellis | |
Consultant, Speaker | Iveric Bio | |
Consultant | OcuTerra | |
Speaker | Optos | |
Maria Sampalis OD (faculty) | Consultant | Tarsus |
Consultant | Allergan | |
Consultant | Zeiss | |
Brad Sutton OD (faculty) | N/A | Nothing to disclose |
Neel Vaidya MD (faculty) | Consultant | Dompe |
Consultant | Zeiss | |
Priya Vakharia MD (faculty) | Consultant, Research, Speaker | Regeneron |
Consultant | Alimera | |
Consultant | Bausch + Lomb | |
Consultant | Notal Vision | |
Consultant, Research | EyePoint | |
Consultant, Research, Speaker | Iveric Bio | |
Consultant, Speaker | Apellis | |
Consultant | Novartis | |
Consultant | Ocuphire | |
Stock | Network Eye | |
Stock | Quad C/PRISM | |
Research | 4DMT | |
Research | Bayer | |
Research | Opthea | |
Research | Ocular Therapeutix | |
Research | Mylan | |
Research | Gemini | |
Research | Kodiak | |
Research | NGM | |
Research | Recens Medical | |
Research | Alkahest | |
Research | Ionis | |
Research | RegenxBio | |
Research | Unity | |
Research | Alexion | |
Research, Speaker | Genentech | |
Nadia Waheed MD, MPH (faculty) | Consultant | Nidek |
Consultant | Zeiss | |
Consultant | Topcon (imaging research) | |
Consultant | Ocudyne | |
Consultant | Steath | |
Consultant | Novartis | |
Consultant | Complement Therapeutics | |
Consultant | Saliogen | |
Consultant | Valitor | |
Consultant | Olix | |
Employee | AGTC | |
Basil Williams MD (faculty) | Consultant | Allergan/AbbVie |
Consultant | Castle Biosciences | |
Consultant | EyePoint | |
Consultant | Genentech | |
Consultant | Immunocore | |
Consultant | Regeneron | |
Stock | Lumata Health | |
Yoshihiro Yonekawa MD (faculty) | Consultant | Alcon |
Consultant | Pykus | |
Consultant | Versant Health | |
Dorothy Caputo, MA, BSN, RN - VP, Healthcare
Continuing Education and Operations |
N/A | Nothing to disclose |
Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
International Healthcare Media dba
International Healthcare Education Staff and Planners |
N/A | Nothing to disclose |